PSEN1 and Alzheimer disease: Indeed, if the hypothesis proposed by Xia et al. that FAD-PS1 mutations are loss of function was true, and this could be generally extended to FAD-PS2 mutants as well, a paradigm change in AD pathogenesis would occur, opening new therapeutic venues aimed at restoring, instead of at inhibiting, PS functions [5].